Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

UT researchers uncover mechanism of chemopreventive activity of sulindac

Sep. 27, 1999

Novel karenitecin from BioNumerik inhibits Topo I and is synergistic with a TS inhibitor

Sep. 24, 1999

Stylostatin 2 available for licensing from ASU

Sep. 24, 1999

KRN-8602 studied as new agent for recurrent high-grade glioma

Sep. 24, 1999

New antitumor antibiotic discovered by Yamanouchi

Sep. 23, 1999

TNP-470 evaluated in patients with metastatic renal carcinoma

Sep. 23, 1999

Screening by Japanese researchers leads to identification of FJ-5002 as potent telomerase inhibitor

Sep. 23, 1999

Phakellistatins 10 and 11 available for licensing from ASU

Sep. 23, 1999

Neristatin 1 available for licensing from ASU

Sep. 23, 1999

Intratumoral IFN-gamma via retroviral vector assessed in metastatic melanoma

Sep. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...